A Double-Masked, Randomized, Parallel Group, Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial.

Trial Profile

A Double-Masked, Randomized, Parallel Group, Comparison of Olopatadine 0.6% and Fluticasone Proprionate 50mcg Nasal Sprays in a Two Week Seasonal Allergic Rhinitis Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 31 Mar 2010

At a glance

  • Drugs Fluticasone propionate; Olopatadine
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 12 Mar 2010 Planned number of patients changed from 100 to 130 as reported by ClinicalTrials.gov.
    • 23 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top